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Abstract 
The field of 3-dimensional (3D) bioprinting have enjoyed rapid development in the past few years for 
the applications in tissue engineering and regenerative medicine. In this review, we summarize the most 
updated developments in 3D bioprinting for the applications in the tissue engineering with a focus on the 
printable biomaterials used as bioinks. These developments include 1) novel printing regimes have been 
enabled by the use of fugitive inks for the creation of intricate structures e.g. vascularized tissue 
constructs; 2) mechanical strength of printed constructs can be enhanced by co-printing soft and hard 
biomaterials; 3) bioprinted in-vitro models for drug testing applications are closer to reality. We 
conclude that the research and application of new bioinks will remain the key highlights of the future 
developments in 3D bioprinting for tissue engineering. 
 
Keywords: Bioprinting, Bioinks, Vascularized tissue, Mechanical Properties, In-vitro models, Drug Testing. 
 
Highlights 
• Novel printing regimes have been developed with fugitive inks to create vascularized tissue constructs. 
• New developments in printable biomaterials have been focused on fine-tuning their mechanical properties.  
• Bioprinted in-vitro tissue models are closer to reality. 
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Introduction 
The field of 3-dimensional (3D) bioprinting have 
enjoyed rapid development in the past few years for the 
applications in tissue engineering and regenerative 
medicine. The rapid developments have been fuelled by the 
new bioprinting technologies, bioprinters, novel printable 
biomaterials or bioinks and exciting applications for in-
vitro models or transplantable tissues. We believe the new 
developments in the bioinks have been the key to many 
recent achievements. Therefore, this article aims to review 
the most recent developments in the field of 3D bioprinting 
for the applications in tissue engineering with a focus on 
printable biomaterials.  
Novel Printing Regimes 
Fugitive inks 
Some research groups are using a different type of 
hydrogel material “fugitive inks” along with standard bio-
inks to support their bioprinted structures.  After the 
printing is completed, the fugitive inks are transformed 
from a gel to a liquid by simply altering the temperature 
and then the resulting liquid can be drained away leaving 
the bioprinted structure behind.  Fugitive inks are used in 
two ways, either around the structure (in the form of a 
supporting bath) to support its creation in free space [1–3] 
or inside the structure to enable the creation of internal 
channels [4]. 
Fugitive support baths 
There have been some interesting improvements made 
to the technique of printing complex structures within a 
hydrogel reservoir to provide support.  Previously when 
printing within a hydrogel, filler material is required to 
restore the resulting voids and crevasses left by the nozzle 
as it travels through the hydrogel material [1]. However, a 
new technique called Freeform Reversible Embedding of 
Suspended Hydrogels (FRESH) [2], or more simply 
Freeform Reversible Embedding (FRE) [3], has been 
developed which uses a supporting bath composed of a 
material that exhibits a Bingham plastic rheology, flowing 
as a viscous fluid at high shear stresses but behaving as a 
rigid body at lower shear stresses.  Due to this property of 
the bath, the syringe nozzle can travel through the 
supporting material with negligible resistance while the 
extruded material is supported and the geometry of the 
printed structure is maintained.  In FRESH the supporting 
material is composed of a slurry of gelatin microparticles 
which is melted and washed away by simply raising the 
temperature to 37 °C when the structure is completed [2].  
While FRE utilised a hydrophilic Carbopol gel to support 
the 3D printing of hydrophobic PDMS prepolymer resins; 
after the PDMS print is cured, it can be released by 
liquefying the Carbopol in the presence of ionic solutions 
such as phosphate buffered saline solution [3]. 
Conventionally, supporting materials have special 
properties to allow them to support structures during 
printing i.e. Bingham plastic [2], high-density hydrophobic 
fluorocarbons [5] or more rigid biodegradable materials are 
used.  A novel bioprinting scheme has been developed by 
Ghanizadeh Tabriz et al. [6] wherein 3D cell-laden alginate 
structures are built up using a three-stage cross-linking 
process.  Partially cross-linked alginate is extruded onto a 
porous PMMA platform which is lowered into a bath of 
100mM calcium chloride solution as each layer is 
completed thus further cross-linking the structure before 
finally treating the completed structure with barium 
chloride in order to extend the degradation time of the 
hydrogel.  This technique allows for the creation of cell-
laden structures with overhangs that would normally not be 
possible using conventional extrusion and the encapsulated 
cells exhibit a high survival rate. 
Internal channel creation via fugitive inks 
Another use for fugitive inks is the creation of 
perfusable channels within other structures, these materials 
have the mechanical stability to maintain shape while the 
entire tissue is printed, but can be washed away at a later 
time, leaving perfusable channels in whatever configuration 
is needed [4,7,8]. The standard process creates a regular 
geometric network structure first via bioprinting before cast 
moulding the desired bulk material around it – epoxy resin 
for microfluidic devices or cells suspended within a 
hydrogel – finally the sacrificial structure is removed and 
the resulting perfusable channels are lined with endothelial 
cells [4,9]. 
While the use of fugitive inks to create internal channels 
is not entirely novel – the Lewis group has been using this 
technology to create microvascular-like networks in 
microfluidic devices since 2003 [10] – the technology is 
gradually developing and the complexity of these tissue-
like structures is increasing from simple blocks to more 
complex multi-cellular structures.   
Kolesky et al. [4] showed that by using this technique, 
they can create a thick, perfusable tissue construct. This 
helps to keep cells alive all throughout the construct, and 
more importantly, to perfuse it with growth factors that 
differentiate the printed Mesenchymal Stem Cells (MSCs) 
toward the osteogenic lineage. Lee et al. [8] showed that by 
not only lining the channels with endothelial cells, but also 
incorporating endothelial cells within the printed construct, 
micro-vascularisation is created between the larger 
channels. 
New Developments in Biomaterials for 3D Bioprinting 
Biomaterials traditionally have been defined as materials 
used in biomedical devices, made specifically not to harm 
organs or tissues. However, over time, biomaterials have 
evolved to include a variety of materials. From rigid 
materials, like metals and ceramics for implants, to 
hydrogels for drug delivery and cell encapsulation, to 
nanodots and quantum particles for imaging and drug 
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delivery. The classifications of different biomaterials is 
ever expanding with the vast amount of research being 
done in the field of tissue engineering [11,12]. In the field 
of 3D bioprinting, two major groups of biomaterials for 3D 
printing can be determined. The first being a group of rigid 
curing materials, used mainly as a scaffold for cells, 
providing mechanical support; these materials include 
hydroxyapatite (HA) [13], calcium phosphate [14], Poly-
(e-caprolactone) (PCL) [15], and others. Some of these 
materials are osteogenic and promote cell proliferation on 
their surface, making them perfect for 3D printing bone 
tissue [16].  
The second group consists of soft materials, usually 
hydrogels, into which cells can be incorporated, and printed 
at the same time. When cells or biochemical molecules are 
incorporated in these materials, it is considered a bioink. 
This form of bioprinting is increasing in popularity, as it 
allows you to not only provide a 3D environment that 
mimics native extracellular matrix [17], it also allows for 
patterning of the cells [18,19].  
 
Constructs made in this way lack the mechanical 
strength to be used for the tissue engineering of hard 
tissues, like bone or cartilage.  Visser et al. [20] proposed a 
solution in the form of reinforced hydrogels. A PCL 
microfiber scaffold with a porosity of 93-98% was made 
using a method called melt electrospinning writing, and 
subsequently infused with either alginate or gelatin 
methacrylate (GelMA). The constructs with the cross-
linked gels show a synergistically increased stiffness, 
compared to the gels or the microfiber scaffold alone. 
Using traditional Melt printing, Daly et al. [21] were also 
able to reinforce their hydrogels with PCL to elevate the 
compressive equilibrium modulus from their hydrogels into 
the range of articular cartilage. Another principle used to 
enhance the mechanical properties of hydrogels is the use 
of nanofibers. These can be used to enforce a hydrogel by 
forming an internal random network [22] or, by aligning 
them, increasing the tensile strength [23] or tune the matrix 
compressive modulus [24]. 
Silk is a material that seems to be getting more and more 
attention as a biomaterial. Silk is a natural occurring 
material, referring to protein fibres produced by several 
insects and spiders [25]. It is mainly Silk Fibroin that is 
being used to create hydrogels. Gelation can happen 
without any important secondary structural changes; 
intramolecular cross-linking between protein chains 
happens with the aid of electrostatic interaction, hydrogen 
bonds and hydrophobic interactions, forming strong β-
sheets [26]. The gelation time can be shortened with the aid 
of physical changes as lowering the pH [27], increasing the 
Temperature [28], sonication [29] or by adding chemical 
crosslinking agents [30]. Silk is a good material for 
bioprinting, as it has good mechanical stability [25,31], and 
has shown to allow cells to attach and proliferate [32]. Jose 
et al. show that mechanical properties, such as viscosity, 
yield stress, and solubility can be modified with the 
addition of non-toxic polyols, creating more possibilities 
for use in printing [33]. Schacht et al. have shown that 
recombinant silk can be used for 3D bioprinting by letting a 
silk-cell mixture gel overnight before using them with 
extrusion printing. By incorporating the cell adhesion 
peptide motif RGD they were able to increase cell adhesion 
and proliferation [28]. The same group showed that this silk 
biomaterial has enough mechanical strength to print larger, 
more intricate structures [34].  
Another subset of materials that are looking very 
promising for bioprinting, are synthetic self-assembling 
peptides. Although short peptide groups have been 
incorporated in other bio-inks on numerous occasions [35–
37], for instance to allow cell adhesion, there aren’t many 
groups using just peptides for bioprinting [38]. The 3D 
network of nanofibers created by these peptides could 
resemble the native ECM, providing a good environment 
for cells to survive and proliferate, while maintaining 
structural integrity [39]. Mechanical properties, as well as 
stimuli-responsive gelation can be completely engineered, 
by modulating factors like amino acid sequence, number of 
repeating units and final peptide concentration [38,40]. Li 
et al. created a 2-part bio-ink out of polypeptides and DNA 
[41]. The first part contains a polypeptide, conjugated with 
a specific DNA sequence, and the second bio-ink contains a 
complementary DNA-linker, both bio-inks staying liquid 
until mixed. By making use of a valve-based bioprinter 
with multiple printing heads, the bio-inks could be 
deposited alternately, creating a structure with 
mechanically tuneable strength that is completely 
biodegradable and doesn’t impede on cell activity in any 
way [41].  
Applications of Bioprinting 
One of the strongest features of bioprinting is the fact 
that it is so versatile. It can be used for basic research, 
research in the fields of Tissue Engineering and 
Regenerative Medicine, and drug testing [42]. 
Bioprinting of the liver has some interest as it will allow 
testing of drugs for drug induced liver injury [43]. Nguyen 
et al. [44] show that by 3D bioprinting hepatocytes at a 
high density with endothelial and stellate cells, in an in 
vivo-like architecture, they can create tissues that were able 
to show the hepatotoxicity of a compound whose 
hepatotoxic potential could not be assessed by any other 
standard pre-clinical model. Bioprinting hepatic cells for 
toxicity can be combined with organ-on-a-chip technology 
[45] by printing directly onto the chip. When bioprinting is 
combined with conventional 3D printing methods, it is 
even possible to print cells on top of a 3D printed chip, 
creating a one-step protocol [46]. Faulkner-Jones et al. [47] 
provides us with promising work regarding induced 
pluripotent stem cells (iPSCs), as they were able to bioprint 
iPSCs in multilayer constructs, while maintaining their 
ability to differentiate into hepatocyte-like cells. This could 
open the doors for patient specific drug testing and 
stratified medicine. Ma et al. [43] also used hepatic cells 
derived from iPSCs in combination with supporting cells to 
create a patient specific hepatic model that mimics the 
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native architecture. In this research, they show one of the 
biggest strengths of 3D bioprinting: being able to determine 
the location of different cell types.  
Another type of tissue for which bioprinting is used to 
create a better in vitro model is cancerous tissue [48]. 
Current two- and three-dimensional models present 
limitations as the complexity of tumours are not replicated 
and the tissues do not possess vascular networks [49]. 
Using Bioprinting techniques, complex interactions such as 
cancer cell dynamics during vascularization can be 
researched [50,51]. Metastasis of cancer cells is one of the 
biggest dangers of tumours. However, not enough 
biomimetic models are available for research. Zhou et al. 
[13] were able to research cancer metastasis into bone by 
3D bioprinting a cell-laden bone matrix, providing a 
microenvironment that mimics native bone tissue. Using 
this model, they were able to research the morphology, 
migration and interaction with bone stromal cells of breast 
cancer cells. Zhao et al. [52] used 3D bioprinting to create a 
new 3D tumour model that showed a higher proliferation 
rate and a higher chemoresistance compared to the 2D 
model. This shows that 3D printing can help develop in 
vitro models that are closer to reality.  
Apart from drug testing, a big goal for bioprinting is to 
create transplantable tissues [43]. However, one of the 
biggest challenges of whole-organ engineering is that to 
create clinically relevant tissue, it needs to be vascularised 
[53]. Therefore, it is not remarkable that using bioprinting 
to create blood vessels, or vascularised tissue is a hot topic 
of research [54]. Bioprinting vascularization can be divided 
in two groups: bioprinting the actual vessels [55] and 
bioprinting tissue with nutrient channels [54].  
By building up a vessel layer by layer, it is possible to 
create the intricate structures of hollow, branched blood 
vessels [6,56] and larger self-supporting structures [57]. 
Hinton et al. [2] showed they can create an entire, full-size, 
perfusable human right-hand coronary arterial tree out of 
alginate using FRESH printing. However, the real 
challenge of bioprinting lies in the creation of larger, 
vascularized tissues [7]. Some research shows printing with 
hollow fibres [58], which can be lined with endothelial 
cells, to create 3D constructs that are completely perfusable 
[59]. Another method to create perfusable channels in 
constructs is by printing with fugitive inks as discussed 
previously.  
Hard tissue fabrication also benefits from 3D bioprinting 
[60]. In the fabrication of bone and cartilage an important 
factor is the mechanical strength of the construct, as 
mechanical stability is an important function of these 
tissues [20,61,62]. Kang et al. [63] were able to print 
mechanically stable constructs by co-printing cell-laden 
hydrogels with a biodegradable polymer. At the same time, 
the incorporation of microchannels in the design allows 
nutrients and oxygen to penetrate these constructs of a 
clinically relevant size. Wang et al. [64] showed the 
possibility of using Adipose derived Stem Cells (ASCs) to 
differentiate in situ towards the osteogenic lineage as a way 
to use a patient’s own cells as a source for the bioprinting. 
Conclusions 
Besides the exciting developments, challenges remain to 
apply 3D bioprinting for tissue engineering applications. 
The novel use of fugutive inks have led to the creation of 
intricate, cell-laden structures including thick, vascularized 
tissues. However, it remains challenging to create 
vascularized tissues that can be sustained in in-vivo 
environments. For bioprinting without fugutive inks, fine-
tuning mechanical properties for printable biomaterials 
have been the focus of the recent research.  The more 
established applications appear to be hard tissue 
engineering where bioprinted bone and cartilage constructs 
have been in-vivo tested. On the other hand, bioprinted soft 
tissues including liver and tumour tissues have been 
demonstrated to create in-vitro models for drug testing 
applications, which is closer to reality than bioprinted 
tissues for medical transplantion. In the past few years, 
many new exciting developments in the bioprinting field 
has been enabled by the bioinks, we therefore envisage that 
the new breakthough in bioinks will remain the key 
highlights of the future developments in 3D bioprinting for 
tissue engineering. 
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Fig. 1: Biomaterials for use in 3D bioprinting. (A-C) Highly organized microfibers 
of PCL are used to reinforce hydrogels for hard tissue engineering. (A)Thin PCL 
fibres are deposited by using melt-electrospinning in a direct writing mode. (B) 
fibres were stacked in a 0-90 orientation at a 1mm interval. (C) detailed image of 
fibres that fused at cross-sections. (D) 3D printed construct made from DNA-
peptide hydrogel, strong enough to be picked up (E) Silk peptide hydrogels are 
mechanically strong enough to create large, intricate structures. (F) close up of 
cell encapsulated in silk peptide hydrogels, in 2 (F) or 8 (F’) layers. A life dead 
staining of human fibroblasts in the gel (G) shows good cell survival. (H) 
Demonstration of solubility modification of silk by the addition of polyols. Blue 
strands were printed with insoluble Silk:Glycerol (SG) and green strands with 
silk (S). After the addition of water, the silk strands solve in roughly 15 seconds, 
leaving only the Silk:Glycerol strands.  
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Fig. 2 Applications of bioprinting. (A,B) Bioprinted 3D Liver Tissue allows 
hepatotoxic effects to be discovered in vitro. The cytotoxic effects of 
trovafloxacin could be seen in concentrations as low as 0.8µM (A) using 3D 
bioprinted liver tissue(B), whereas a concentration of 100µM was necessary to 
see the effect in 2D culture. (C,D) one step fabrication of organ-on-a-chip can be 
realized using 3D Bioprinting. (C) A schematic overview of the bioprinting 
process that leads to a perfusable microchannel (D). (E,F) Induced Pluripotent 
Stem Cells (IPS-cells) can be used for personal drug testing. (E) A model of 3D 
printed alginate structures (40 layers) which were used to differentiate IPS-cells 
towards the hepatic lineage in 3D. IPS-derived hepatocyte-like cells(green) can 
very precisely be patterned with supporting cells (red) in a physiological 
relevant pattern. (G,H) Bioprinting has allowed us to investigate the cell-cell 
interaction between glioblastoma cells (Green) and endothelial cells (red). Over 
time, the glioblastoma cells proliferated and migrated towards a perfused 
channel, lined with endothelial cells.  (I,J) Hard Tissue printing allows us to 
create structural stable constructs with clinically relevant sizes. (I) A 3D printed 
mandible bone defect construct, based on human CT image data. Cells printed in 
the construct were able to undergo osteogenic differentiation, as shown by the 
Alizarin red S staining (J).  (K,L) By printing with fugitive materials, channels can 
be created in bioprinted constructs, which allows perfusion of bigger constructs. 
(K) A thick construct was perfused with medium and growth factors through 
micro-channels (L), allowing for in situ osteogenic differentiation of human 
Mesenchymal Stem Cells. Micro-channels were lined with Human Umbilical Vein 
Endothelial Cells (HUVECs, red). Osteocalcin  was stained in purple, nuclei in 
blue using DAPI and actin in green.  
 
